PDE7A1 Antibodies

Santa Cruz Biotechnology provides a broad selection of PDE7A1 monoclonal antibodies for investigating phosphodiesterase 7A1 protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE7A1 is an enzyme that regulates intracellular signaling pathways by hydrolyzing cyclic adenosine monophosphate (cAMP). This regulation influences numerous physiological processes, including inflammation, neuronal signaling, and cardiac function. Research focused on PDE7A1 continues to reveal important insights about neurodegenerative disorders and cardiovascular diseases. Investigating PDE7A1 expression and activity patterns helps advance understanding of cellular signaling mechanisms. Detailed characterization of PDE7A1 localization and interactions provides valuable information about its biological functions. Advanced research techniques enable precise monitoring of PDE7A1 activity in various cellular contexts. Extensive experimental approaches support thorough investigation of PDE7A1's role in health and disease states. Santa Cruz Biotechnology monoclonal antibodies for PDE7A1 help researchers worldwide make meaningful contributions to scientific knowledge about cellular signaling pathways.